1887

Chapter 28 : Antibiotic Resistance in

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Antibiotic Resistance in , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817572/9781555813291_Chap28-1.gif /docserver/preview/fulltext/10.1128/9781555817572/9781555813291_Chap28-2.gif

Abstract:

The basic mechanisms that generate and propagate antibiotic resistance can all be found within ; understanding the evolving pattern of antibiotic resistance in our favourite model organism will continue to be of importance as we try to understand and prevent the expansion and spread of bacterial antibiotic resistance in the years to come. Antibiotic therapy is often necessary to resolve infections caused by . Life threatening conditions such as meningitis, sepsis and bacteremia all require rapid antibiotic intervention to prevent high levels of mortality. Infections caused by range from those that are mild and self-limiting to those that display very high mortality. It is worth noting though that can exhibit examples of all these antibiotic resistance mechanisms concomitantly; for example, resistance to quinolones requires mutation in the target site topoisomerase genes, β-lactam resistance is primarily mediated by β-lactamase enzymes, the Tet efflux pumps determine tetracycline resistance, and novel hydrofolate reductase alleles allow tolerance to trimpethoprim. The presence of all these resistance mechanisms in shows the versatility of this pathogen and validates the study of the emergence and dissemination of antibiotic resistance in. Research into the evolutionary selection of antibiotic resistance genes and their stability within a population will again provide important information regarding the appropriate use of antibiotics, is an ideal candidate for such research as we know more about this organism than any other.

Citation: Webber M, Piddock L. 2005. Antibiotic Resistance in , p 374-386. In White D, Alekshun M, McDermott P (ed), Frontiers in Antimicrobial Resistance. ASM Press, Washington, DC. doi: 10.1128/9781555817572.ch28

Key Concept Ranking

Urinary Tract Infections
0.5127104
Escherichia coli
0.46723416
Human Pathogenic Bacteria
0.4476757
DNA Topoisomerase IV
0.43216187
0.5127104
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817572.chap28
1. Aarestrup, F. M.,, F. Bager,, N. E. Jensen,, M. Madsen,, A. Meyling,, and H. C. Wegener. 1998. Resistance to antimicrobial agents used for animal therapy in pathogenic-, zoonoticand indicator bacteria isolated from different food animals in Denmark: a baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP). APMIS 106:745770.
2. Ahmed, A. A.,, H. Osman,, A. M. Mansour,, H. A. Musa,, A. B. Ahmed,, Z. Karrar,, and H. S. Hassan. 2000. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Am. J. Trop. Med. Hyg. 63:259263.
3. Alekshun, M. N.,, and S. B. Levy. 1999. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol. 7:410413.
4. Alobwede, I.,, F. H. M’Zali,, D. M. Livermore,, J. Heritage,, N. Todd,, and P. M. Hawkey. 2003. CTX-M extended-spectrum beta-lactamase arrives in the UK. J. Antimicrob. Chemother. 51:470471.
5. Arpin, C.,, V. Dubois,, L. Coulange,, C. Andre,, I. Fischer,, P. Noury,, F. Grobost,, J. P. Brochet,, J. Jullin,, B. Dutilh,, G. Larribet,, I. Lagrange,, and C. Quentin. 2003. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob. Agents Chemother. 47:35063514.
6. Baraniak, A.,, J. Fiett,, W. Hryniewicz,, P. Nordmann,, and M. Gniadkowski. 2002. Ceftazidime-hydrolysing CTX-M-15 extended- spectrum beta-lactamase (ESBL) in Poland. J. Antimicrob. Chemother. 50:393396.
7. Barbosa, T. M.,, and S. B. Levy. 2000. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J. Bacteriol. 182:34673474.
8. Bauernfeind, A.,, I. Stemplinger,, R. Jungwirth,, S. Ernst,, and J. M. Casellas. 1996. Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob. Agents Chemother. 40:509513.
9. Bax, R.,, R. Bywater,, G. Cornaglia,, H. Goossens,, P. Hunter,, V. Isham,, V. Jarlier,, R. Jones,, I. Phillips,, D. Sahm,, S. Senn,, M. Struelens,, D. Taylor,, and A. White. 2001. Surveillance of antimicrobial resistance--what, how and whither? Clin. Microbiol. Infect. 7:316325.
10. Bell, J. M.,, J. D. Turnidge,, A. C. Gales,, M. A. Pfaller,, and R. N. Jones. 2002. Prevalence of extended spectrum betalactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn. Microbiol. Infect. Dis. 42:193198.
11. Bischoff, K. M.,, D. G. White,, P. F. McDermott,, S. Zhao,, S. Gaines,, J. J. Maurer,, and D. J. Nisbet. 2002. Characterization of chloramphenicol resistance in beta-hemolytic Escherichia coli associated with diarrhea in neonatal swine. J. Clin. Microbiol. 40:389394.
12. Bonnet, R. 2004. Growing group of extended-spectrum betalactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:114.
13. Bonnet, R.,, C. Dutour,, J. L. Sampaio,, C. Chanal,, D. Sirot,, R. Labia,, C. De Champs,, and J. Sirot. 2001. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob. Agents Chemother. 45: 22692275.
14. Bonnet, R.,, C. Recule,, R. Baraduc,, C. Chanal,, D. Sirot,, C. De Champs,, and J. Sirot. 2003. Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52: 2935.
15. Bradford, P. A.,, P. J. Petersen,, I. M. Fingerman,, and D. G. White. 1999. Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease. J. Antimicrob. Chemother. 44:607610.
16. Braoudaki, M.,, and A. C. Hilton. 2004. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J. Clin. Microbiol. 42:7378.
17.Brooks M. B., P. S. Morley, D. A. Dargatz, D. R. Hyatt, M. D. Salman, and B. L. Akey. 2003. Survey of antimicrobial susceptibility testing practices of veterinary diagnostic laboratories in the United States. J. Am. Vet. Med. Assoc. 15:222 (2):16873. s
18.Bryan A., N. Shapir, and M. J. Sadowsky. 2004. Frequency and distribution of tetracycline resistance genes in genetically diverse, nonselected, and nonclinical Escherichia coli strains isolated from diverse human and animal sources. App. Env. Micro. 70:25032507.
19. Burman, W. J.,, P. E. Breese,, B. E. Murray,, K. V. Singh,, H. A. Batal,, T. D. MacKenzie,, J. W. Ogle,, M. L. Wilson,, R. R. Reves,, and P. S. Mehler. 2003. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am. J. Med. 115:358364.
20. Chanawong, A.,, F. H. M’Zali,, J. Heritage,, J. H. Xiong,, and P. M. Hawkey. 2002. Three cefotaximases, CTX-M-9, CTXM- 13, and CTX-M-14, among Enterobacteriaceae in the People’s Republic of China. Antimicrob. Agents Chemother. 46:630637.
21. Chang, C. Y.,, L. L. Chang,, Y. H. Chang,, T. M. Lee,, and S. F. Chang. 2000. Characterisation of drug resistance gene cassettes associated with class 1 integrons in clinical isolates of Escherichia coli from Taiwan, ROC. J. Med. Microbiol. 49:10971102.
22. Chopra, I.,, and M. Roberts. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65:232260.
23. Davies, J.,, and G. D. Wright. 1997. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 5:234240.
24. Diekema, D. J.,, M. A. Pfaller,, and R. N. Jones. 2002. Agerelated trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000. Int. J. Antimicrob. Agents 20:412418.
25. Doern, G. V.,, R. N. Jones,, M. A. Pfaller,, K. C. Kugler,, and M. L. Beach. 1999. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). Diagn. Microbiol. Infect. Dis. 34:6572.
26. Esaki H.,, A. Morioka,, K. Ishihara,, A. Kojima,, S. Shiroki,, Y. Tamura,, and T. Takahashi. 2004. Antimicrobial susceptibility of Salmonella isolated from cattle, swine and poultry (2001- 2002): report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program. J. Antimicrob. Chemother. 53: 266270.
27. Everett, M. J.,, Y. F. Jin,, V. Ricci,, and L. J. Piddock. 1996. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:23802386.
28. Fluit, A. C.,, F. J. Schmitz,, and J. Verhoef. 2001. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. Eur. J. Clin. Microbiol. Infect. Dis. 20:188191.
29. Fluit, A. C.,, F. J. Schmitz,, and J. Verhoef. 2001. Multiresistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens. Int. J. Antimicrob. Agents 18: 147160.
30. Fraise, A. P. 2002. Biocide abuse and antimicrobial resistance— a cause for concern? J. Antimicrob. Chemother. 49:1112.
31. Gellert, M.,, K. Mizuuchi,, M. H. O’Dea,, and H. A. Nash. 1976. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. USA 73:38723876.
32. George, A. M.,, and S. B. Levy. 1983. Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J. Bacteriol. 155:531540.
33. Gilbert, P.,, and A. J. McBain. 2003. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin. Microbiol. Rev. 16:189208.
34. Gilbert, P.,, A. J. McBain,, and S. F. Bloomfield. 2002. Biocide abuse and antimicrobial resistance: being clear about the issues. J. Antimicrob. Chemother. 50:137139.
35. Gordon, K. A.,, and R. N. Jones. 2003. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn. Microbiol. Infect. Dis. 45:295301.
36. Gould, I. M. 2002. Antibiotic policies and control of resistance. Curr. Opin. Infect. Dis. 15:395400.
37. Guay, D. R. 2001. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 61:353364.
38. Hadley, C. 2004. Overcoming resistance. EMBO J. 5:550552.
39. Heritage, J.,, F. H. M’Zali,, D. Gascoyne-Binzi,, and P. M. Hawkey. 1999. Evolution and spread of SHV extendedspectrum beta-lactamases in gram-negative bacteria. J. Antimicrob. Chemother. 44:309318.
40. Hooper, D. C. 1999. Mechanisms of fluoroquinolone resistance. Drug Resist. Updates 2:3855.
41. Hooton, T. M. 2003. The current management strategies for community-acquired urinary tract infection. Infect. Dis. Clin. North Am. 17:303332.
42. Huovinen, P.,, L. Sundstrom,, G. Swedberg,, and O. Skold. 1995. Trimethoprim and sulfonamide resistance. Antimicrob. Agents Chemother. 39:279289.
43. Jensen, V. F.,, J. Neimann,, A. M. Hammerum,, K. Molbak,, and H. C. Wegener. 2004. Does the use of antibiotics in food animals pose a risk to human health? An unbiased review? J. Antimicrob. Chemother. May 12 [Epub ahead of print].
44. Johnson, J. R.,, A. Gajewski,, A. J. Lesse,, and T. A. Russo. 2003. Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J. Clin. Microbiol. 41:57985802.
45. Jones, M. E.,, D. C. Draghi,, J. A. Karlowsky,, D. F. Sahm,, and J. S. Bradley. 2003. Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002. Ann. Clin. Microbiol. Antimicrob. 25:3.
46. Jones, R. N.,, K. C. Kugler,, M. A. Pfaller,, and P. L. Winokur. 1999. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn. Microbiol. Infect. Dis. 35:5563.
47. Kahlmeter, G. 2000. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens— interim report. J. Antimicrob. Chemother. 46 (Suppl. 1):1522.
48. Kahlmeter, G. 2003. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J. Antimicrob. Chemother. 51:6976.
49. Kahlmeter, G. 2003. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int.J. Antimicrob. Agents 22 (Suppl 2): 4952.
50. Kahlmeter, G.,, and P. Menday. 2003. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J. Antimicrob. Chemother. 52:128131.
51. Kaper, J. B.,, J. P. Nataro,, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123140.
52. Karlowsky, J. A.,, C. Thornsberry,, M. E. Jones,, and D. F. Sahm. 2003. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin. Infect. Dis. 36:183187.
53. Karlowsky, J. A.,, L. J. Kelly,, C. Thornsberry,, M. E. Jones,, A. T. Evangelista,, I. A. Critchley,, and D. F. Sahm. 2002. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network. Int. J. Antimicrob. Agents 19: 2131.
54. Karlowsky, J. A.,, L. J. Kelly,, C. Thornsberry,, M. E. Jones,, and D. F. Sahm. 2002. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob. Agents Chemother. 46:25402545.
55. Karlowsky, J. A.,, M. E. Jones,, C. Thornsberry,, I. Critchley,, L. J. Kelly,, and D. F. Sahm. 2001. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int. J. Antimicrob. Agents 18:121127.
56. Karlowsky, J. A.,, M. E. Jones,, C. Thornsberry,, I. R. Friedland,, and D. F. Sahm. 2003. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob. Agents Chemother. 47:16721680.
57. Karlowsky, J. A.,, M. E. Jones,, D. C. Draghi,, C. Thornsberry,, D. F. Sahm,, and G. A. Volturo. 2004. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann. Clin. Microbiol. Antimicrob. 3:7.
58. Lacey, R. W. 1984. Antibiotic resistance in Staphylococcus aureus and streptococci. Br. Med. Bull. 40:7783.
59. Lecointre, G.,, L. Rachdi,, P. Darlu,, and E. Denamur. 1998. Escherichia coli molecular phylogeny using the incongruence length difference test. Mol. Biol. Evol. 15:16851695.
60. Levy, S. B. 2001. Antibacterial household products: cause for concern. Emerg. Infect. Dis. 7:512515.
61. Levy, S. B. 2002. Active efflux, a common mechanism for biocide and antibiotic resistance. Symp. Ser. Soc. Appl. Microbiol. 65S71S.
62. Levy, S. B.,, L. M. McMurry,, V. Burdett,, P. Courvalin,, W. Hillen,, M. C. Roberts,, and D. E. Taylor. 1989. Nomenclature for tetracycline resistance determinants. Antimicrob. Agents Chemother. 33:13731374.
63. Lewis, M. T.,, A. C. Gales,, H. S. Sader,, M. A. Pfaller,, and R. N. Jones. 2000. Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998). Diagn. Microbiol. Infect. Dis. 37:6374.
64. Li, X. Z.,, and H. Nikaido. 2004. Efflux-mediated drug resistance in bacteria. Drugs 64:159204.
65. Livermore, D.M.,, and N. Woodford. 2000. Carbapenemases: a problem in waiting? 3:48995.
66. Livermore, D. M. 1998. Beta-lactamase-mediated resistance and opportunities for its control. J. Antimicrob. Chemother. 41 (Suppl D):2541.
67. Llano-Sotelo, B.,, E. F. Azucena, Jr., L. P. Kotra, S. Mobashery, and C. S. Chow. 2002. Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. Chem. Biol. 9:455463.
68. Mansouri, S.,, and S. Shareifi. 2002. Antimicrobial resistance pattern of Escherichia coli causing urinary tract infections, and that of human fecal flora, in the southeast of Iran. Microb. Drug Resist. 8:123128.
69. Martinez-Martinez, L.,, A. Pascual,, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797799.
70. Mathai, D.,, R. N. Jones,, and M. A. Pfaller. 2001. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn. Microbiol. Infect. Dis. 40:129136.
71. Matthew, M.,, R. W. Hedges,, and J. T. Smith. 1979. Types of beta-lactamase determined by plasmids in gram-negative bacteria. J. Bacteriol. 138:657662.
72. McBain, A. J.,, R. G. Ledder,, P. Sreenivasan,, and P. Gilbert. 2004. Selection for high-level resistance by chronic triclosan exposure is not universal. J. Antimicrob. Chemother. 53:772777.
73. McMurry, L. M.,, J. C. Cullinane,, and S. B. Levy. 1982. Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains. Antimicrob. Agents Chemother. 22:7919.
74. McMurry, L. M.,, M. L. Aldema-Ramos,, and S. B. Levy. 2002. Fe(2+)- tetracycline-mediated cleavage of the Tn10 tetracycline efflux protein TetA reveals a substrate binding site near glutamine 225 in transmembrane helix 7. J. Bacteriol. 184:51135120.
75. McMurry, L. M.,, M. Oethinger,, and S. B. Levy. 1998. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 166:305309.
76. McOsker, C. C.,, and P. M. Fitzpatrick. 1994. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J. Antimicrob. Chemother. 33 (Suppl A):2330.
77. Medeiros, A. A. 1997. Evolution and dissemination of betalactamases accelerated by generations of beta-lactam antibiotics. Clin. Infect. Dis. 24 (Suppl 1):S19S45.
78. Mingeot-Leclercq, M. P.,, Y. Glupczynski,, and P. M. Tulkens. 1999. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:727737.
79. Miriagou, V.,, E. Tzelepi,, D. Gianneli,, and L. S. Tzouvelekis. 2003. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1. Antimicrob. Agents Chemother. 47:395397.
80. Miro, E.,, F. Navarro,, B. Mirelis,, M. Sabate,, A. Rivera,, P. Coll,, and G. Prats. 2002. Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period. Antimicrob. Agents Chemother. 46:39913994.
81. Moland, E. S.,, J. A. Black,, A. Hossain,, N. D. Hanson,, K. S. Thomson,, and S. Pottumarthy. 2003. Discovery of CTX-Mlike extended-spectrum beta-lactamases in Escherichia coli isolates from five US States. Antimicrob. Agents Chemother. 47:23822383.
82. Monnet, D. L. 2000. Toward multinational antimicrobial resistance surveillance systems in Europe. Int. J. Antimicrob. Agents 15:91101.
83. Mori, H. 2004. From the sequence to cell modelling: comprehensive functional genomics in Escherichia coli. J. Biochem. Mol. Biol. 37:8392.
84. Mulvey, M. R.,, E. Bryce,, D. Boyd,, M. Ofner-Agostini,, S. Christianson,, A. E. Simor,, and S. Paton. 2004. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48:12041214.
85. Murray, I. A.,, and W. V. Shaw. 1997. O-Acetyltransferases for chloramphenicol and other natural products. Antimicrob. Agents Chemother. 41:16.
86. Nataro, J. P.,, and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142201.
87. Nelson, M. L.,, and S. B. Levy. 1999. Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob. Agents Chemother. 43:17191724.
88. Nikaido, H. 1998. Multiple antibiotic resistance and efflux. Curr. Opin. Microbiol. 1:516523.
89. Odeh, R.,, S. Kelkar,, A. M. Hujer,, R. A. Bonomo,, P. C. Schreckenberger,, and J. P. Quinn. 2002. Broad resistance due to plasmid- mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Clin. Infect. Dis. 35:140145.
90. Oethinger, M.,, I. Podglajen,, W. V. Kern,, and S. B. Levy. 1998. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli . Antimicrob. Agents Chemother. 42:20892094.
91. Oliver, A.,, J. C. Perez-Diaz,, T. M. Coque,, F. Baquero,, and R. Canton. 2001. Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain. Antimicrob. Agents Chemother. 45:616620.
92. Pai, H.,, H. J. Lee,, E. H. Choi,, J. Kim,, and G. A. Jacoby. 2001. Evolution of TEM-related extended-spectrum beta-lactamases in Korea. Antimicrob. Agents Chemother. 45:36513653.
93. Palucha, A.,, B. Mikiewicz,, W. Hryniewicz,, and M. Gniadkowski. 1999. Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J. Antimicrob. Chemother. 44:489499.
94. Patton, J. P.,, D. B. Nash,, and E. Abrutyn. 1991. Urinary tract infection: economic considerations. Med. Clin. North Am. 75:495513.
95. Peng, H.,, and K. J. Marians. 1993. Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions. J. Biol. Chem. 268:2448124490.
96. Pfaller, M. A.,, J. Acar,, R. N. Jones,, J. Verhoef,, J. Turnidge,, and H. S. Sader. 2001. Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program. Clin. Infect. Dis. 32(Suppl 2):S156S167.
97. Phillips, I.,, M. Casewell,, T. Cox,, B. De Groot,, C. Friis,, R. Jones,, C. Nightingale,, R. Preston,, and J. Waddell. 2004. Antibiotic use in animals. J. Antimicrob. Chemother. 53:885.
98. Phillips, I.,, M. Casewell,, T. Cox,, B. De Groot,, C. Friis,, R. Jones,, C. Nightingale,, R. Preston,, and J. Waddell. 2004. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J. Antimicrob. Chemother. 53:2852.
99. Picard, B.,, J. S. Garcia,, S. Gouriou,, P. Duriez,, N. Brahimi,, E. Bingen,, J. Elion,, and E. Denamur. 1999. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67:546553.
100. Piddock, L. J. 1995. Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994. Drugs 49(Suppl 2): 2935.
101. Piddock, L. J. 1999. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58(Suppl 2):1118.
102. Pitout, J. D.,, K. S. Thomson,, N. D. Hanson,, A. F. Ehrhardt,, E. S. Moland,, and C. C. Sanders. 1998. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob. Agents Chemother. 42:13501354.
103. Quinteros, M.,, M. Radice,, N. Gardella,, M. M. Rodriguez,, N. Costa,, D. Korbenfeld,, E. Couto,, and G. Gutkind. 2003. Extended- spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob. Agents Chemother. 47:28642867.
104. Rennie, R. P.,, R. N. Jones,, and A. H. Mutnick. 2003. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn. Microbiol. Infect. Dis. 45:287293.
105. Reynolds, R.,, N. Potz,, M. Colman,, A. Williams,, D. Livermore,, and A. MacGowan. 2004. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001- 2002: the BSAC Bacteraemia Resistance Surveillance Programme. J. Antimicrob. Chemother. 53:10181032.
106.Rodriguez-Martinez JM, Pascual A, Garcia I, Martinez- Martinez L. 2003. Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase. J. Antimicrob. Chemother. 52:703706.
107. Russo, T. A.,, and J. R. Johnson. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes. Infect. 5:449456.
108. Sabate, M.,, E. Miro,, F. Navarro,, C. Verges,, R. Aliaga,, B. Mirelis,, and G. Prats. 2002. Beta-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J. Antimicrob. Chemother. 49: 989997.
109. Sader, H. S.,, D. J. Biedenbach,, and R. N. Jones. 2003. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). Diagn. Microbiol. Infect. Dis. 47:361364.
110. Sader, H. S.,, M. A. Pfaller,, R. N. Jones,, G. V. Doern,, A. C. Gales,, P. L. Winokur,, and K. C. Kugler. 1999. Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program. Braz. J. Infect. Dis. 3:97110.
111. Sader, H. S.,, R. N. Jones,, A. C. Gales,, P. Winokur,, K. C. Kugler,, M. A. Pfaller,, and G. V. Doern. 1998. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. Diagn. Microbiol. Infect. Dis. 32:289301.
112. Sader, H. S.,, R. N. Jones,, and J. B. Silva. 2002. Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns. Diagn. Microbiol. Infect. Dis. 44:281288.
113. Sader, H. S.,, R. N. Jones,, S. Andrade-Baiocchi,, and D. J. Biedenbach. 2002. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn. Microbiol. Infect. Dis. 44:273280.
114. Sahm, D. F.,, C. Thornsberry,, D. C. Mayfield,, M. E. Jones,, and J. A. Karlowsky. 2001. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother. 45:14021406.
115. Saladin, M.,, V. T. Cao,, T. Lambert,, J. L. Donay,, J. L. Herrmann,, Z. Ould-Hocine,, C. Verdet,, F. Delisle,, A. Philippon,, and G. Arlet. 2002. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 209:161168.
116. Schroeder, C. M.,, C. Zhao,, C. DebRoy,, J. Torcolini,, S. Zhao,, D. G. White,, D. D. Wagner,, P. F. McDermott,, R. D. Walker,, and J. Meng. 2002. Antimicrobial resistance of Escherichia coli O157 isolated from humans, cattle, swine, and food. Appl. Environ. Microbiol. 68:576581.
117. Schroeder, C. M.,, J. Meng,, S. Zhao,, C. DebRoy,, J. Torcolini,, C. Zhao,, P. F. McDermott,, D. D. Wagner,, R. D. Walker,, and D. G. White. 2002. Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans. Emerg. Infect. Dis. 8:14091414.
118. Scoulica, E.V.,, I. K. Neonakis,, A. I. Gikas,, and Y. J. Tselentis. 2004. Spread of bla(VIM-1)-producing E. coli in a university hospital in Greece. Genetic analysis of the integron carrying the bla(VIM-1) metallo-beta-lactamase gene. Diagn. Microbiol. Infect. Dis. 48:167172.
119. Siu, L. K.,, P. L. Lu,, J. Y. Chen,, F. M. Lin,, and S. C. Chang. 2003. High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment. Antimicrob. Agents Chemother. 47:21382144.
120. Skold, O. 2001. Resistance to trimethoprim and sulfonamides. Vet. Res. 32:261273.
121. Sotto, A.,, C. M. De Boever,, P. Fabbro-Peray,, A. Gouby,, D. Sirot,, and J. Jourdan. 2001. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study. J. Clin. Microbiol. 39:438444.
122. Teuber, M. 1999. Spread of antibiotic resistance with foodborne pathogens. Cell Mol. Life Sci. 56:755763.
123.Turnidge J. 2004. Antibiotic use in animals—prejudices, perceptions and realities. J. Antimicrob. Chemother. 53:2627.
124. Turnidge, J.,, J. Bell,, D. J. Biedenbach,, and R. N. Jones. 2002. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int. J. Antimicrob. Agents 20:1017.
125. Unal, S.,, R. Masterton,, and H. Goossens. 2004. Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programme. Int. J. Antimicrob. Agents 23: 155163.
126. Van den Bogaard, A. E.,, and E. E. Stobberingh. 1999. Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs 58:589607.
127. Vergis, E. N.,, C. Brennen,, M. Wagener,, and R. R. Muder. 2001. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch. Intern. Med. 161:23782381.
128. Vetting, M.,, S. L. Roderick,, S. Hegde,, S. Magnet,, and J. S. Blanchard. 2003. What can structure tell us about in vivo function? The case of aminoglycoside-resistance genes. Biochem. Soc. Trans. 31:520522.
129. Vila, J.,, M. Vargas,, J. Ruiz,, M. Corachan,, M. T. Jimenez De Anta,, and J. Gascon. 2000. Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas. Antimicrob. Agents Chemother. 44:17311733.
130. Wang, M.,, J. H. Tran,, G. A. Jacoby,, Y. Zhang,, F. Wang,, and D. C. Hooper. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47:22422248.
131. Wang, H.,, J. L. Dzink-Fox,, M. Chen,, and S. B. Levy. 2001. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob. Agents Chemother. 45:15151521.
132. Webber, M. A.,, and L. J. Piddock. 2001. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone- resistant clinical and veterinary isolates of Escherichia coli. Antimicrob. Agents Chemother. 45:15501552.
133. White, D. G.,, L. J. Piddock,, J. J. Maurer,, S. Zhao,, V. Ricci,, and S. G. Thayer. 2000. Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli. Antimicrob. Agents Chemother. 44:28972899.
134. White, D. G.,, S. Zhao,, P. F. McDermott,, S. Ayers,, S. Gaines,, S. Friedman,, D. D. Wagner,, J. Meng,, D. Needle,, M. Davis,, and C. DebRoy. 2002. Characterization of antimicrobial resistance among Escherichia coli O111 isolates of animal and human origin. Microb. Drug Resist. 8:139146.
135. White, D. G.,, S. Zhao,, S. Simjee,, D. D. Wagner,, and P. F. McDermott. 2002. Antimicrobial resistance of foodborne pathogens. Microbes. Infect. 4:405412.
136. Witte, W. 1997. Impact of antibiotic use in animal feeding on resistance of bacterial pathogens in humans. Ciba Found. Symp. 207:6171.
137. Yagi, T.,, H. Kurokawa,, K. Senda,, S. Ichiyama,, H. Ito,, S. Ohsuka,, K. Shibayama,, K. Shimokata,, N. Kato,, M. Ohta,, and Y. Arakawa. 1997. Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like betalactamase genes. Antimicrob. Agents Chemother. 41:26062611.
138. Yagi, T.,, H. Kurokawa,, N. Shibata,, K. Shibayama,, and Y. Arakawa. 2000. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol. Lett. 184:5356.
139. Yamasaki, K.,, M. Komatsu,, T. Yamashita,, K. Shimakawa,, T. Ura,, H. Nishio,, K. Satoh,, R. Washidu,, S. Kinoshita,, and M. Aihara. 2003. Production of CTX-M-3 extended-spectrum beta-lactamase and IMP-1 metallo beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. J. Antimicrob. Chemother. 51:631638.
140. Zervos, M. J.,, E. Hershberger,, D. P. Nicolau,, D. J. Ritchie,, L. K. Blackner,, E. A. Coyle,, A. J. Donnelly,, S. F. Eckel,, R. H. Eng,, A. Hiltz,, A. G. Kuyumjian,, W. Krebs,, A. McDaniel,, P. Hogan,, and T. J. Lubowski. 2003. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin. Infect. Dis. 37:16431648.
141. Zhao, C.,, B. Ge,, J. De Villena,, R. Sudler,, E. Yeh,, S. Zhao,, D. G. White,, D. Wagner,, and J. Meng. 2001. Prevalence of Campylobacter spp., Escherichia coli, and Salmonella serovars in retail chicken, turkey, pork, and beef from the Greater Washington, D.C. area. Appl. Environ. Microbiol. 67:54315436.
142. Zhao, S.,, D. G. White,, P. F. McDermott,, S. Friedman,, L. English,, S. Ayers,, J. Meng,, J. J. Maurer,, R. Holland,, and R. D. Walker. 2001. Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob. Agents Chemother. 45:36473650.

Tables

Generic image for table
Table 1

Common conditions where antibiotics are indicated for the treatment of infections

UK, United Kingdom.

Citation: Webber M, Piddock L. 2005. Antibiotic Resistance in , p 374-386. In White D, Alekshun M, McDermott P (ed), Frontiers in Antimicrobial Resistance. ASM Press, Washington, DC. doi: 10.1128/9781555817572.ch28
Generic image for table
Table 2

Fluoroquinolone resistance rates recorded by surveillance programs around the world

Care should be taken when comparing data from one study with that from another if different interpretive criteria have been applied; hence, we have indicated which guidelines have been used by each study.

Many studies include data for more than one fluoroquinolone as well as nalidixic acid. Ciprofloxacin is the most commonly used indicator fluoroquinolone.

Data from the ECO.SENS project are interpreted by using recommendations of the Swedish Reference Group for Antimicrobials (SRGA).

The data are for groups of countries put together according to region. The overall rate of 6% includes data from Spain and Portugal, which have much higher levels of resistance than other countries.

Data from the SENTRY program are interpreted using recommendations of the National Committee for Clinical Laboratory Standards (NCCLS).

Data from the TRUST and TSN programs are interpreted using recommendations of the NCCLS.

The highest resistance was in Spain, and the lowest was in Germany.

Citation: Webber M, Piddock L. 2005. Antibiotic Resistance in , p 374-386. In White D, Alekshun M, McDermott P (ed), Frontiers in Antimicrobial Resistance. ASM Press, Washington, DC. doi: 10.1128/9781555817572.ch28
Generic image for table
Table 3

β-Lactam resistance rates reported by surveillance programs around the world

Data from the SENTRY program (NCCLS methodology).

Data from the TSN program (NCCLS methodology).

Data from the ECO.SENS program (Swedish Reference Group for Antimicrobials methodology).

Citation: Webber M, Piddock L. 2005. Antibiotic Resistance in , p 374-386. In White D, Alekshun M, McDermott P (ed), Frontiers in Antimicrobial Resistance. ASM Press, Washington, DC. doi: 10.1128/9781555817572.ch28

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error